Early immunological responses to the mRNA SARS-CoV-2 vaccine in patients with neuromuscular disorders

BACKGROUNDS: Intramuscular injection of the SARS-CoV-2 vaccine has raised concerns about its use in patients with neuromuscular disorders (NMDs). We evaluated the response of patients with NMDs to the BNT162b2 vaccine. METHODS: Healthy subjects, patients with spinal muscular atrophy (SMA), and patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwayama, Hideyuki, Ishihara, Naoko, Kawahara, Kohei, Madokoro, Yuta, Togawa, Yasuko, Muramatsu, Kanji, Murakami, Ayuka, Kuru, Satoshi, Kumagai, Toshiyuki, Ohashi, Wataru, Nanya, Kengo, Hasegawa, Shinji, Katsuno, Masahisa, Okumura, Akihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558231/
https://www.ncbi.nlm.nih.gov/pubmed/36248823
http://dx.doi.org/10.3389/fimmu.2022.996134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558231/
https://www.ncbi.nlm.nih.gov/pubmed/36248823
http://dx.doi.org/10.3389/fimmu.2022.996134

Ejemplares similares